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M. Halak,* M.A. Goodman and S.R. BakerDepartment of Vascular Surgery, Sir Charles Gairdner Hospital, Perth, WA, AustraliaObjective. To carry out a retrospective analysis of the short and mid-term target vessels (TV) patency following fenestrated
endovascular aortic repair (f-EVAR) of abdominal aneurysm (AAA).
Patients and methods. Seventeen f-EVAR patients were analysed. The Zenith (Cook) fenestrated graft was used in all
cases. Bare renal stents were used where good apposition existed between the stent graft and the aortic wall, and covered
stents were chosen when this apposition appeared deficient.
Results. A total of 35 TV were treated: twenty with small fenestration and 15 with a scallop. Procedural technical success
was achieved in 16 out of 17 patients. All TV were perfused at the completion angiography. Access to TV through small
fenestrations was achieved in 18 out of 20 vessels. After a mean follow-up of 20.5 months no type I endoleaks were detected.
No late complications were observed in any of the stented TV. One patient with perioperative bilateral renal artery occlusion
remains on haemodialysis. One non-target renal artery, opposite a scallop was unintentionally covered. One kidney, initially
perfused via a un-stented scallop fenestration, was atrophied 14 months post surgery. One patient died from heart failure.
Conclusions. f-EVAR is a valid and safe treatment option. Our series and the world literature demonstrates aO90% TV
preservation rate. Long-term intensive surveillance is required.Keywords: Fenestration; EVAR; AAA: target vessels; Renal artery; SMA; Endovascular.Introduction
Fenestrated endovascular aortic repair (f-EVAR) of
abdominal aortic aneurysm (AAA) is still in its infancy.
Short-necked infrarenal and juxta-renal AAA in high-
risk patients are currently considered the principal
indications for f-EVAR.1,2 The f-EVAR enables the
advancement of the sealing stent to a more proximal
segment of the aorta in order to optimise wall contact.
Over 800 AAAs have been treated with f-EVAR
throughout the world. Early results are encouraging.
The incidence of type I endoleak (EL) and of AAA
related death is low, and preservation of over 90% of
target vessels is reported.3–7
Fenestrations may be either large or small or a scallop.
Fenestrations are designed to align at deployment with
the orifice of the target vessel. Thus, stent graft planning
depends upon critical appreciation of the aortic neck
anatomy.3,4,8,9 Stenting in f-EVAR will maintain this
alignment of the fenestration to the target vessel. Whening author. Dr Moshe Halak, MD, Department of
ery, Carmel Medical Center, 7 Michal St, 34362 Haifa,
: shalak@bigpond.net.au
0124 + 05 $35.00/0 q 2006 Elsevier Ltd. All rights reserthe apposition of the fenestration against the aortic wall
at the orifice of the target vessel is close, a bare stent is
appropriate. If there is no apposition or a potential gap is
likely to be present, a covered stent is required to avoid a
leak at this site (Fig. 1).
Fenestrated-EVAR aims to preserve and maintain
target vessels patency and sealing. However, compli-
cations may occur during and after the procedure,
which may compromise perfusion. These include
immediate coverage and occlusion of the target vessel
secondary to errors in planning or mal-alignment
during deployment. Late complications include graft
migration, rotation; and in situ stenosis and thrombo-
sis, secondary to intimal hyperplasia.
We have analysed the short and mid-term target
vessel patency in a single centre experience with 17
patients treated with f-EVAR.Patients and Methods
Between February 2002 and February 2005, 17 patients
with AAA greater than 50 mm in maximal diameter
underwent f-EVAR. In all patients the anatomy of theEur J Vasc Endovasc Surg 32, 124–128 (2006)
doi:10.1016/j.ejvs.2006.01.012, available online at http://www.sciencedirect.com onved.
Fig. 1. Apposition of the stent graft against the aortic wall.
(A) Case for a bare renal stent. (B) Case for a covered renal
stent.
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Eleven patients had a juxta-renal aneurysm with at
least one visceral vessel originating from an aneur-
ysmal segment.
Two patients of this group had proximal anasto-
motic false aneurysms following AAA repair. Seven
patients had short infra-renal necks (!5 mm).Planning
Planning was based on a CTangiography and required
1 mm slices from proximal coeliac down to the lowest
renal artery and multi-planar reconstructions at all
levels. Assessment of target vessel position, number,
size, as well as luminal diameter, neck thrombus and
angulation was necessary to calculate the position and
size of the fenestration or scallop, as well as the choice
of covered vs bare stents.
Aortography and selective catheterisation of the
target vessel confirmed the ease of entry and clarified
the anatomy. Access vessel calibre and tortuosity was
assessed by both modalities.Fig. 2. A close look at a small fenestration. (A) A non-
reinforced fenestration. (B) Nitinol ring reinforced fenestra-
tion. (1) (thick arrow) Large fenestration. (2) (thin arrow)
Small fenestration.Types of fenestration
Fenestrations were small (SF) 6!6 mm2 or 6!8 mm2,
or large (LF) 8–12 mm. Scallop fenestration (ScF) had a
minimum width of 10 mm and height range 6–12 mm.
The distance from the proximal fabric edge was at least
10 mm for LF and 15 mm for SF. All small, large, and
scallop fenestrations were reinforced with a nitinol
ring to ensure sealing when a covered stent was used
(Fig. 2).Stent graft
The Zenith (WA Cook Australia Pty. Ltd, Brisbane,
Australia) fenestrated graft was used in all cases. The
device description and implantation technique has
been described elsewhere.2,3,4,6Renal stents
Bare renal stents (Balloon expandable: Jostent renal,
Jomed AG Beringen, Switzerland; or genesis, cordis
endovascular—LJ Roden, The Netherlands) were used
where good apposition existed between the stent graft
and the aortic wall (Fig. 1(A)). Covered renal stents
(Jostent-stent graft, Jomed Gmbh; Rangendinger,
Germany) were chosen when apposition between the
stent graft and the aorta appeared deficient (Fig. 1(B)).
The nitinol ring reinforced fenestration permits
a covered stent to seal at this point as well as within
the target vessel. All renal stents were positioned so
that at least 25% was left protruding into the stent
graft. This protruding portion of the renal stent wasEur J Vasc Endovasc Surg Vol 32, August 2006
M. Halak et al.126subsequently flared with a larger angioplasty balloon
(10–12 mm).Follow-up
All patients were followed-up according to the Cook
Zenith protocol thereafter. Cases, in which the
completion angiogram raised doubts with regard to
type I endoleak underwent CTA prior to discharge.
Renal function was assessed regularly.Results
A total of 35 target vessels were treated in 17 patients:
twenty with small fenestration and 15 with scallops.
No large fenestrations were used in this series
(Table 1). Nineteen fenestrations had nitinol ring
reinforcement. Mean follow-up was 20.5 months
(range 4–40).Procedural technical success
Procedural technical success was achieved in 16 out of
17 patients. All the target vessels were perfused at the
completion angiography. There were no conversions
to open surgery.Small fenestrations
Access to target vessels was achieved in 18 out of 20
vessels. Of the 20 SF 17 were stented: six with
bare stents, and 11 with covered stents. One small
diameter accessory renal artery was intentionally not
stented.
In one patient with severely angulated neck, access
was not achieved to one renal artery and to the
superior mesenteric artery. These six target vessels
were initially perfused via a proximal endoleak.
Subsequent attempts to correct the situation controlled
the endoleak but could not preserve flow to the renal
arteries.Table 1. Distribution of vessels incorporated into the fenestrated
device and type of fenestration
Scallop
fenestration
Small
fenestration
Large
fenestration
SMA* 7 1 0
Renal artery
Main 8 18 0
Accessory 0 1 0
Total 15 20 0
* SMA, superior mesenteric artery.
Eur J Vasc Endovasc Surg Vol 32, August 2006Scallop fenestrations
Fifteen target vessels were treated with ScF. Access to
target vessels was achieved in all eight renal artery ScF
during deployment. No attempt was made to gain
access to the SMA. One renal artery ScF was stented
with a bare stent. One non-target renal artery, opposite
a scalloped artery was unintentionally covered and
could not be salvaged.Follow-up morbidity and mortality
No type I endoleaks were detected. No late compli-
cations were observed in any of the target vessels that
had been stented (17 out of 18 stents). No specific
adverse effects can be related to the use of covered or
bare stents.
One kidney, initially perfused via a un-stented
scallop fenestration, was confirmed to have atrophied
14 months post surgery. Renal artery occlusion was
demonstrated. One patient with the perioperative
bilateral renal artery occlusion remains on haemodia-
lysis. Overall, four kidneys atrophied associated with
stenting. In only one case the renal artery was stented.
One kidney was lost intra-operatively (the case of non-
target renal artery, opposite a scalloped fenestration);
two kidneys (same patient) peri-operatively (the
patient with severe angulated neck and an endoleak);
and one kidney during follow-up. Only one patient
ended up on permanent haemodialysis. One patient in
the series died 7 months post procedure. The cause of
death was not graft related.Discussion
The principal goal of fenestrated endovascular aortic
grafts is to extend the applicability of EVAR in
medium to high-risk patient with an unsuitable
proximal sealing zone.
f-EVAR achieves this goal by moving the sealing
zone proximally. Consequently, f-EVAR must accom-
modate at least one of the four visceral vessels.
Compromised perfusion remains a potential
hazard. Accurate positioning of the stent-graft at the
time of the procedure and prevention of post
procedural migration of the stent-graft along the aortic
wall is crucial to minimise this. This particularly
applies to small fenestrations when the tolerance to
movement is low and partial covering of the orifice
may not be detected on initial imaging.
Anderson et al. showed that without the use of
trans-graft stenting, five renal arteries were either
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The Fate of Target Vessels After Fenestrated Endovascular Aortic Repair 127occluded or poorly perfused by the endo-graft.4
However, mandatory need for stenting raises other
issues of concern. This relates to the potentially
traumatic effect of the stent on the target artery. In
f-EVAR the stents are functioning as ‘bridging side-
arms’ between the relatively rigid stent graft
and the normal target vessel. Repetitive stent
movement may provoke intimal hyperplasia and
accelerated atherosclerosis leading to stenosis or
thrombosis.
In reviewing the combined series in Table 2, we
observe that short and mid-term patency of 387 target
vessels in 139 patients was 95% (nZ368). These figures
are expected to improve now that the stenting of small
fenestration has become an integral part of the
procedure.
Our current policy is to stent ScF to the renal
arteries and we emphasise, that stenting of a
scalloped fenestration to the renal artery is also of
value in securing patency of the fenestration against
migration and/or rotation. Verhoeven et al. rec-
ommended that ScF should not be stented as sealing
is not the issue.3 Our case of kidney loss 14 months
post procedure might confirm that this potential
problem does exist.
As stated above, we reserved the use of covered
renal stents to cases where a potential residual gap
between the stent-graft and the aortic wall was likely.
No adverse effects on target vessels were found to be
related to this practice but concerns persist. Long-term
anti-platelet therapy is strongly recommended for this
group. Covered stenting of the target vessels demands
intensive long-term surveillance.
Perfusion of target vessels should be regularly
assessed in the post f-EVAR patient. Duplex ultra-
sound can detail the blood flow velocities as well as
early signs of ischaemic nephropathy (i.e. cortex
medulla ratio and the kidney length). Interval
physiological renal tests might be of value (e.g.
calculated glomerular filtration rate-cGFR, serum
creatinine-Sr-Cr, and renal scintography).
We believe that fenestrated EVAR can be advocated
as a safe procedure with respect to the patency of the
target vessels in the hands of experienced operators.
While there are potential risks, the absence of graft
related mortality in this and other reported series is
encouraging and strengthens ones ability to advocate
f-EVAR as a valid option for treating high-risk
patients. We have demonstrated a small incidence of
target vessel complications. Meticulous attention to
detail in planning and deployment should keep this to
an absolute minimum. Although with experience, the
spectrum of patients offered this technique mayEur J Vasc Endovasc Surg Vol 32, August 2006
M. Halak et al.128widen, complex neck anatomy may always remain a
barrier.
In conclusion, f-EVAR is a valid and safe treatment
option for high-risk patients. The world literature
demonstrates aO95% target vessels preservation rate
following f-EVAR. Stenting of small fenestration as an
integral part of the procedure should improve these
results further. f-EVAR mandates modification of pre
and post EVAR work-up protocols with more specific
investigation of the targeted vessels. The technique
incorporated the use of covered stents in a proportion
of patients. This requires long-term intensive surveil-
lance. Target vessels stenting appears to be safe,
therefore, stenting through scalloped fenestration to
the renal arteries is recommended to prevent long-
term complications.References
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